Bozena Skotnicka Selected Research

Otitis Media with Effusion

1/2020	Vascular endothelial growth factor and transforming growth factor β in hypertrophic adenoids in children suffering from otitis media with effusion.
1/2020	Selected cytokines in hypertrophic adenoids in children suffering from otitis media with effusion.
1/2012	Production of cytokines by mononuclear cells of hypertrophic adenoids in children with otitis media with effusion.
7/2010	[Long term sequelae of otitis media with effusion during childhood].
6/2010	Chosen factors of T and B cell apoptosis in hypertrophic adenoid in children with otitis media with effusion.
11/2009	[Evaluation of percentage of lymphocytes B with expression of co-receptors CD 40, CD22 and CD72 in hypertrophied adenoid at children with otitis media with effusion].
3/2009	[Expression of chosen chemokine receptors on the Th lymphocytes in children with hypertrophied adenoids with otitis media with effusion].
1/2008	[Expression Fas and FasL antigen protein of lymphocytes T and B in hypertrophied adenoid in children with otitis media with effusion].
1/2008	Proinflammatory and immunoregulatory cytokines in the middle ear effusions.
1/2006	[The cytofluorometric opinion of expression of adhesion molecules CD11a and CD54 on lymphocytes T and B in children's hypertrophied adenoids, which are sick on the otitis media with effusion].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bozena Skotnicka Research Topics

Disease

12	Otitis Media with Effusion 01/2020 - 01/2002
6	Otitis Media 01/2020 - 01/2002
4	Hypertrophy 01/2020 - 01/2008
1	Hearing Loss (Hearing Impairment) 07/2010
1	Nasal Obstruction 01/2008
1	Inflammation (Inflammations) 01/2008
1	Cholesteatoma 01/2003
1	Rhinosinusitis 01/2003
1	Middle Ear Cholesteatoma 01/2003
1	Cicatrix (Scar) 01/2002

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 01/2020 - 01/2008
2	Proteins (Proteins, Gene)FDA Link 06/2010 - 01/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2020
1	Interleukin-5 (Interleukin 5)IBA 01/2012
1	fas Receptor (CD95 Antigen)IBA 06/2010
1	Immunoglobulin G (IgG)IBA 11/2009
1	Immunoglobulin A (IgA)IBA 11/2009
1	Chemokine ReceptorsIBA 03/2009
1	AntigensIBA 01/2008
1	Interleukin-10 (Interleukin 10)IBA 01/2008
1	InterleukinsIBA 01/2008
1	Interleukin-6 (Interleukin 6)IBA 01/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2007
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 01/2006
1	Monoclonal AntibodiesIBA 07/2005
1	Keratins (Keratin)IBA 01/2003
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2003
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2003
1	lipoarabinomannan (LAM)IBA 01/2002

Therapy/Procedure

3	Adenoidectomy 01/2020 - 01/2008
3	Middle Ear Ventilation (Tympanostomy) 07/2010 - 01/2002
1	Lasers (Laser) 01/2002